REVIEW ARTICLE
Year : 2012  |  Volume : 11  |  Issue : 1  |  Page : 1-15

Schistosomiasis ( chemoprophylaxis and treatments)


Department of Therapeutical Chemistry, National Research Centre, Pharmaceutical and Drug Industries Research Division, Cairo, Egypt

Correspondence Address:
Magdy I El-Zahar
Department of Therapeutical Chemistry, National Research Centre, Pharmaceutical and Drug Industries Research Division, El-Bohowth St., P.O. Box 12622, Dokki, Cairo
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.7123/01.EPJ.0000415037.38143.d4

Rights and Permissions

Schistosomiasis is a chronic parasitic disease affecting about 207 million individuals worldwide. It is still a major health problem in many tropical and subtropical countries, as well as for travelers from developed countries. The treatment strategies of schistosomiasis can be divided into two main routes: (a) chemotherapy treatment including trivalent antimony compounds, hycanthone mesylate, niridazole, metrifonate, oxamniquine, oltipraz, artemisinins, albendazole, amoscanate mirazid, and praziquantel; (b) vaccines that may play an important role in the control of schistosomiasis in the future.



[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1595    
    Printed30    
    Emailed0    
    PDF Downloaded189    
    Comments [Add]    

Recommend this journal